Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Predictors of the appropriateness of first presentation in an university ophthalmology outpatient clinic: an analysis of sociodemographic factors].

Die Ophthalmologie·2025

Same author

[Neurotrophic keratopathy and corneal ulcers in diabetes mellitus].

Die Ophthalmologie·2025

Same author

[Incidence of delirium in ophthalmology].

Die Ophthalmologie·2024

Same author

Automatic inference of ICD-10 codes from German ophthalmologic physicians' letters using natural language processing.

Scientific reports·2024

Same author

Aggressive fibromatosis in a child: a diagnostic challenge.

Pathology·2022

Same author

[Early diagnosis of keratoconus].

Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft·2021

Same journal

Corneal Neurotisation in Neurotrophic Keratopathy: A Retrospective Analysis of Functional Outcomes and Clinical Courses.

Klinische Monatsblatter fur Augenheilkunde·2026

Same journal

Evaluating the Long-term Success and Safety of Canaloplasty in Glaucoma Patients.

Klinische Monatsblatter fur Augenheilkunde·2026

Same journal

Imbalanced Trace Elements as Risk Factors in the Pathogenesis of Glaucoma.

Klinische Monatsblatter fur Augenheilkunde·2026

Same journal

Malnutrition as a Risk Factor for Cerebral and Glaucomatous Neurodegeneration - Mechanisms and Therapeutic Strategies.

Klinische Monatsblatter fur Augenheilkunde·2026

Same journal

Impact of Wearing a Face Mask on the Reliability of Standard Automated Perimetry in Glaucoma Patients and Suspects: a Retrospective Longitudinal Study.

Klinische Monatsblatter fur Augenheilkunde·2026

Same journal

[Siderotic Cataract Eight Months After Intralenticular Metallic Foreign Body: A Case Report and Surgical Management].

Klinische Monatsblatter fur Augenheilkunde·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Mar 19, 2026

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

[Crosslinking in Keratoconus].

S J Lang¹, T Reinhard¹

¹Klinik für Augenheilkunde, Universitätsklinikum Freiburg.

Klinische Monatsblatter Fur Augenheilkunde

|June 18, 2016

Summary

This summary is machine-generated.

Corneal crosslinking can halt keratoconus progression, but not all patients benefit. Avoid this procedure for patients without progression to prevent risks like scarring and infection.

More Related Videos

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Published on: January 6, 2018

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

Related Experiment Videos

Last Updated: Mar 19, 2026

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia

Published on: January 6, 2018

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

Area of Science:

Ophthalmology
Corneal Diseases
Surgical Innovation

Background:

Keratoconus is a progressive corneal disease causing thinning and protrusion.
Younger patients are at higher risk for keratoconus progression.
Corneal crosslinking (CXL) aims to halt this progression.

Purpose of the Study:

To evaluate the efficacy and risks of corneal crosslinking for keratoconus.
To determine if all keratoconus patients benefit from CXL.
To establish criteria for appropriate CXL patient selection.

Main Methods:

Review of six randomized controlled trials (RCTs) on corneal crosslinking.
Analysis of keratometric data to assess treatment efficacy.
Evaluation of reported adverse events and patient progression post-CXL.

Main Results:

RCTs confirm the efficacy of CXL in halting keratoconus progression based on keratometric data.
Progression was observed in a subset of patients who received CXL in two trials.
Identified risks include corneal scarring, haze, endothelial cell damage, and infection.

Conclusions:

Corneal crosslinking is effective for many keratoconus patients.
Not all patients achieve cessation of progression with CXL.
To mitigate risks, CXL should be reserved for patients with documented keratoconus progression.